Valneva SE
Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile t… Read more
Valneva SE - Asset Resilience Ratio
Valneva SE (INRLF) has an Asset Resilience Ratio of 0.03% as of September 2020. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2005–2019)
This chart shows how Valneva SE's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Valneva SE's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $150.00K | 0.03% |
| Total Liquid Assets | $150.00K | 0.03% |
Asset Resilience Insights
- Limited Liquidity: Valneva SE maintains only 0.03% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Valneva SE Industry Peers by Asset Resilience Ratio
Compare Valneva SE's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for Valneva SE (2005–2019)
The table below shows the annual Asset Resilience Ratio data for Valneva SE.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2019-12-31 | 0.00% | $0.00 | $264.72 Million | -- |
| 2018-12-31 | 0.00% | $0.00 | $229.91 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $189.34 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $206.88 Million | -- |
| 2015-12-31 | 0.00% | $0.00 | $275.19 Million | -- |
| 2014-12-31 | 0.01% | $19.00K | $227.52 Million | -1.43pp |
| 2013-12-31 | 1.44% | $3.66 Million | $254.39 Million | -19.48pp |
| 2012-12-31 | 20.92% | $11.22 Million | $53.67 Million | -7.34pp |
| 2011-12-31 | 28.25% | $20.65 Million | $73.08 Million | +18.50pp |
| 2010-12-31 | 9.75% | $7.75 Million | $79.50 Million | +0.06pp |
| 2008-12-31 | 9.70% | $4.01 Million | $41.38 Million | -19.50pp |
| 2007-12-31 | 29.20% | $11.56 Million | $39.58 Million | +17.93pp |
| 2006-12-31 | 11.27% | $1.68 Million | $14.92 Million | -11.83pp |
| 2005-12-31 | 23.10% | $3.37 Million | $14.60 Million | -- |